Jonathan L Slaughter

Contact Information

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

PediatricsNeonatology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Jonathan L. Slaughter

Biography

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Neonatology

Physician Team

Center for Perinatal Research

Principal Investigator

Neonatology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Neonatology

Awards, Honors & Organizations

Member, American Academy of Pediatrics Member, Society for Pediatric Research Member, International Society for Pharmacoepidemiology

Research

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.   Publications

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

Professional Experience

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

Research Funding

National Heart, Lung, and Blood Institute, United States National Institutes of Health Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment. National Heart, Lung, and Blood Institute, United States National Institutes of Health Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

Contact Information

Pediatrics

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Research

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Connect with Jonathan L. Slaughter

Connect on Twitter

Connect on ResearchGate

Connect on LinkedIn

Connect on Doximity

Contact Information

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

PediatricsNeonatology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Jonathan L. Slaughter

Biography

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Neonatology

Physician Team

Center for Perinatal Research

Principal Investigator

Neonatology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Neonatology

Awards, Honors & Organizations

Member, American Academy of Pediatrics Member, Society for Pediatric Research Member, International Society for Pharmacoepidemiology

Research

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.   Publications

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

Professional Experience

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

Research Funding

National Heart, Lung, and Blood Institute, United States National Institutes of Health Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment. National Heart, Lung, and Blood Institute, United States National Institutes of Health Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

Contact Information

Pediatrics

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Research

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Connect with Jonathan L. Slaughter

Connect on Twitter

Connect on ResearchGate

Connect on LinkedIn

Connect on Doximity

Contact Information

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

PediatricsNeonatology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Jonathan L. Slaughter

Contact Information

• Call us at:
• (614) 722-3624
• Fax us at:
• (614) 722-4541
• PediatricsNeonatology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Jonathan L. Slaughter

Biography

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Biography

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Biography

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Jonathan L. Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research within The Abigail Wexner Research Institute at Nationwide Children’s Hospital and an Associate Professor of Pediatrics at The Ohio State University. Dr. Slaughter’s ultimate goal is to improve outcomes important to neonatal patients and their families through research that leads directly to improvements in neonatal clinical care. His patient-centered research program focuses on comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

• Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Neonatology

Physician Team

Center for Perinatal Research

Principal Investigator

Neonatology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Neonatology

Academic and Clinical Areas

Neonatology

Physician Team

Center for Perinatal Research

Principal Investigator

Neonatology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Neonatology

Academic and Clinical Areas

Neonatology

Physician Team

Center for Perinatal Research

Principal Investigator

Neonatology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Neonatology

Neonatology

Physician Team

Center for Perinatal Research

Principal Investigator

Neonatology Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Neonatology

• Neonatology
• Physician Team
• Center for Perinatal Research
• Principal Investigator
• Neonatology Fellowship
• Faculty
• Primary Department
• Pediatrics
• Primary Section
• Neonatology

Awards, Honors & Organizations

Member, American Academy of Pediatrics Member, Society for Pediatric Research Member, International Society for Pharmacoepidemiology

Awards, Honors & Organizations

Member, American Academy of Pediatrics Member, Society for Pediatric Research Member, International Society for Pharmacoepidemiology

Awards, Honors & Organizations

Member, American Academy of Pediatrics Member, Society for Pediatric Research Member, International Society for Pharmacoepidemiology

Member, American Academy of Pediatrics Member, Society for Pediatric Research Member, International Society for Pharmacoepidemiology

• Member, American Academy of Pediatrics
• Member, Society for Pediatric Research
• Member, International Society for Pharmacoepidemiology

Research

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.   Publications

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

Research

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.   Publications

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

Research

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.   Publications

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.   Publications

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

Lab(s)

Center for Perinatal Research

Dr. Slaughter’s two major NIH-funded research projects, 1) “Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes” (R01HL145032) and the 2) PIVOTAL Trial (UG3HL161338) focus on treatments and outcomes related to patent ductus arteriosus (PDA). Dr. Slaughter also serves as the Nationwide Children’s Hospital co-investigator/alternate principal investigator for the NICHD Neonatal Research Network.

Lab(s)

Center for Perinatal Research

• Center for Perinatal Research

                  Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;  

                


                  Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6;  1-10.

                


                  Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.

                


                  King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals. J Perinatol. 2022 Sep 26;  

                


                  Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.

                


                  Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;  

                


                  Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;  

                


                  Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.

                


                  Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.

                


                  Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;  

                


                  Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.

                


                  Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.

                


                  Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.

                


                  Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;  

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.

                


                  Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.

                


                  Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.

                


                  Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.

                


                  Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.

                


                  King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.

                


                  Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.

                


                  Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.

                


                  Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;  

                


                  Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.

                


                  Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.

                


                  Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.

                


                  Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;  

                


                  Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;  

                


                  Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.

                


                  Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;  

                


                  Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.

                


                  Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4: 

                


                  Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.

                


                  Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.

                


                  Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.

                


                  Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

View More Publications

• Wright ML, Klamer BG, Bonachea E, Spencer JD, Slaughter JL, Mohamed TH. Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days. Pediatr Nephrol. 2023 Jan 4;
• Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Oct 6; 1-10.
• Mohamed TH, Slaughter JL. Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants-Active Drivers of Increased Disease or Associated Bystanders? JAMA Netw Open. 2022 Sep 1; 5: e2234474.
• King BC, Hagan J, Richardson T, Berry J, Slaughter JL. Hospital variation in neonatal echocardiography among very preterm infants at US children’s hospitals. J Perinatol. 2022 Sep 26;
• Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, Benitz WE, Garg V. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 Sep 6; 11: e025784.
• Slaughter JL, Kemper AR, Newman TB. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;
• Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Panayotti GMM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Aug 5;
• Han R, Bonachea EM, Jackson K, Conroy S, Slaughter JL, Mahan JD, Mohamed T. Describing patterns in serum creatinine in infants with and without necrotizing enterocolitis. J Perinatol. 2022 Aug 17;
• Venkatesh KK, Lynch CD, Costantine MM, Backes CH, Slaughter JL, Frey HA, Huang X, Landon MB, Klebanoff MA, Khan SS, Grobman WA. Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020. JAMA. 2022 Aug 16; 328: 652-662.
• Barcroft M, McKee C, Berman DP, Taylor RA, Rivera BK, Smith CV, Slaughter JL, El-Khuffash A, Backes CH. Percutaneous Closure of Patent Ductus Arteriosus. Clin Perinatol. 2022 Mar; 49: 149-166.
• Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL. Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol. 2022 Feb 15;
• Sultana Z, Hasenstab KA, Moore RK, Osborn EK, Yildiz VO, Wei L, Slaughter JL, Jadcherla SR. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux. Gastro Hep Adv. 2022; 1: 869-881.
• Rogers LK, Slaughter JL. Editorial: Developmental origins of health and disease: Impact of preterm birth. Front Pediatr. 2022; 10: 1120208.
• Mohamed TH, Klamer B, Mahan JD, Spencer JD, Slaughter JL. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatr Nephrol. 2021 Dec; 36: 3981-3991.
• Ziegler GM, Slaughter JL, Chaudhari M, Singh H, Sánchez PJ, Bunch DR. Preterm to term infant postmenstrual age reference intervals for thyroid-stimulating hormone and free thyroxine. Pediatr Res. 2021 Nov 13;
• King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Hall M, Slaughter JL. Prioritization framework for improving the value of care for very low birth weight and very preterm infants. J Perinatol. 2021 Oct; 41: 2463-2473.
• Armbruster D, Slaughter J, Stenger M, Warren P. Neonatal Anthropometric Measures and Peripherally Inserted Central Catheter Depth. Adv Neonatal Care. 2021 Aug 1; 21: 314-321.
• Zettler E, Rivera BK, Stiver C, Boe B, Cua C, Ball MK, Smith CV, Slaughter JL, Chen B, Callahan R, Backes CH. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol. 2021 Jul; 41: 1621-1626.
• Abdi HH, Backes CH, Ball MK, Talavera-Barber MM, Klebanoff MA, Jadcherla SR, Mohamed TH, Slaughter JL. Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels. J Perinatol. 2021 Apr; 41: 749-755.
• Le VT, Abdi HH, Sánchez PJ, Yossef L, Reagan PB, Slaughter LA, Firestine A, Slaughter JL. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change. Am J Perinatol. 2021 Apr; 38: 469-476.
• King BC, Richardson T, Patel RM, Lee HC, Bamat NA, Patrick SW, Gautham KS, Hall M, Slaughter JL. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol. 2021 Feb; 41: 295-304.
• Scerbo D, Cua CL, Rivera BK, Marzec LC, Smith CV, Slaughter JL, Berman DP, Backes CH. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants. Neoreviews. 2020 Jul; 21: e469-e478.
• Slaughter JL. Neonatal Aerodigestive Disorders: Epidemiology and Economic Burden. Clin Perinatol. 2020 Jun; 47: 211-222.
• Jadcherla SR, Hasenstab KA, Wei L, Osborn EK, Viswanathan S, Gulati IK, Slaughter JL, Di Lorenzo C. Role of feeding strategy bundle with acid-suppressive therapy in infants with esophageal acid reflux exposure: a randomized controlled trial. Pediatr Res. 2020 May 7;
• Harmon HM, Jensen EA, Tan S, Chaudhary AS, Slaughter JL, Bell EF, Wyckoff MH, Hensman AM, Sokol GM, DeMauro SB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020 Apr; 40: 616-627.
• Backes CH, Donovan JL, Slaughter JL. Catheter-based closure of the patent ductus arteriosus in preterm infants: considerations in the design of a randomized trial. J Perinatol. 2019 Nov; 39: 1437-1438.
• Slaughter JL, Cua CL, Notestine JL, Rivera BK, Marzec L, Hade EM, Maitre NL, Klebanoff MA, Ilgenfritz M, Le VT, Lewandowski DJ, Backes CH. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr. 2019 Sep 13; 19: 333.
• Backes CH, Giesinger RE, Rivera BK, Berman DP, Smith CV, Cua CL, Kelleher KJ, McNamara PJ, Slaughter JL. Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US Food and Drug Administration Approval of a Novel Device. J Pediatr. 2019 Jun 26;
• Nealon E, Rivera BK, Cua CL, Ball MK, Stiver C, Boe BA, Slaughter JL, Chisolm J, Smith CV, Cooper JN, Armstrong AK, Berman DP, Backes CH. Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019 Jun 28;
• Kemper AR, Slaughter JL, Newman TB. Shining a Light on Concerns about Phototherapy to Prevent Allergic Skin Disease. Neonatology. 2019 Mar 19; 116: 27.
• Abdi HH, Maitre NL, Benninger KL, Hester ME, Slaughter JL. Gabapentin Use for Hospitalized Neonates. Pediatr Neurol. 2019 Feb 21;
• Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, Backes CH. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019 Jan; 14: 95-99.
• Koboldt DC, Kastury RD, Waldrop MA, Kelly BJ, Mosher TM, McLaughlin H, Corsmeier D, Slaughter JL, Flanigan KM, McBride KL, Mehta L, Wilson RK, White P. In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. Cold Spring Harb Mol Case Stud. 2018 Oct; 4:
• Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018 Sep-Oct; 3: e106.
• Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group.. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 Aug; 104: 239-241.
• Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based closure of the patent ductus arteriosus in lower weight infants. Semin Perinatol. 2018 Jun; 42: 262-268.
• Chaudhari M, Slaughter JL. Thyroid Function in the Neonatal Intensive Care Unit. Clin Perinatol. 2018 Mar; 45: 19-30.

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

Date of Appointment at Nationwide Children’s Hospital: 07/19/2010

Board Certifications

Neonatal-Perinatal Medicine Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2010

Residency

Medical University of South Carolina

Date Completed: 06/30/2007

Medical School

Wake Forest University Baptist Medical Center

Date Completed: 05/17/2004

Undergraduate School

Catawba College

Date Completed: 12/31/2000

• Neonatal-Perinatal Medicine
• Pediatrics

Professional Experience

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

Professional Experience

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

Professional Experience

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

2010 - Present Nationwide Children’s Hospital/The Ohio State University, Assistant Professor of Pediatrics

Research Funding

National Heart, Lung, and Blood Institute, United States National Institutes of Health Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment. National Heart, Lung, and Blood Institute, United States National Institutes of Health Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

Research Funding

National Heart, Lung, and Blood Institute, United States National Institutes of Health Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment. National Heart, Lung, and Blood Institute, United States National Institutes of Health Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

Research Funding

National Heart, Lung, and Blood Institute, United States National Institutes of Health Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment. National Heart, Lung, and Blood Institute, United States National Institutes of Health Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

National Heart, Lung, and Blood Institute, United States National Institutes of Health Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment. National Heart, Lung, and Blood Institute, United States National Institutes of Health Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants (R03HL140272), Principal Investigator

The goal of this study: To utilize “real-world” data to determine whether diuretic and inhaled corticosteroid treatments for evolving and established BPD reduce mortality and severity of BPD in preterm infants at 36-weeks PMA, as compared to no treatment.

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes (R01HL145032), Principal Investigator

The goal of this study: to use a prospective cohort of untreated infants with PDA to predict spontaneous ductal closure timing and to identify clinical risk factors, echo measurements, and biomarkers that are present in the first postnatal month and associated with long-term impairment.

Contact Information

Pediatrics

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Research

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Research

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Research

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Pediatrics

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Research

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Call us at: (614) 722-3624

Fax us at: (614) 722-4541

                    Neonatology700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-3624
• Fax us at:
• (614) 722-4541
• Neonatology700 Children’s DrColumbus, OH 43205 (map)

Call us at: (614) 355-6643

Fax us at: (614) 355-5899

                        The Research Institute at Nationwide Children's Hospital575 Children's Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

• Call us at:
• (614) 355-6643
• Fax us at:
• (614) 355-5899
• The Research Institute at Nationwide Children’s Hospital575 Children’s Crossroads, Research Building III, 5th FloorColumbus, OH 43215 (map)

Connect with Jonathan L. Slaughter

Connect on Twitter

Connect on ResearchGate

Connect on LinkedIn

Connect on Doximity